Business Wire22h
Reprieve Cardiovascular Builds Clinical Momentum with Positive Results from FASTR Pilot Trial and FDA Investigational Device Exemption Approval for Pivotal Trial
Reprieve Cardiovascular, Inc., a development-stage company focused on advancing acute decompensated heart failure (ADHF) ...
idw3h
Therapeutic Designer Peptide to Combat Acute Heart Muscle Weakness
Home > Pressemitteilung: Therapeutic Designer Peptide to ...